CVS Health Corporation
CVS Health Corporation (CVS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CVS · as of Jun 8, 2026
Key Statistics
Explore CVS Health Corporation Data
cvs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 41 · Buy rate: 85.4%
The CVS analyst consensus is Buy, based on ratings from 41 Wall Street analysts over the past 3 months. The average 12-month price target is $102.67, representing +7.03% upside from the current price of $95.93.
Competitors & Peers
cvs competitorsCVS
BMY
CI
COR
ELV
GSKStock Performance
Full HistoryAbout CVS Health Corporation
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and rela…
what is cvs health corporation · cvs stock overview · cvs health corporation company profile · who is cvs health corporation ceo · cvs NYSE · cvs health corporation headquarters · cvs health corporation business segments
About Stock Overview & Key Data
CVS Health Corporation (CVS) is a Healthcare company in the Medical - Healthcare Plans industry, listed on NYSE since Nov 20, 1996. As of the latest trading session, CVS stock price is $95.93, with a market capitalization of $122.4B. The stock has returned +50.22% over the past 12 months and +20.88% year-to-date.
According to 41 Wall Street analysts, the consensus rating for CVS Health Corporation stock is Buy, with an average 12-month price target of $102.67. In fiscal year 2025, CVS Health Corporation reported revenue of $402.1B and net income of $1.8B. For detailed data — including CVS Health Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CVS Health Corporation (CVS) stock price is $95.93. The stock is traded on NYSE under the ticker symbol CVS. The 52-week range is $58.50 – $98.43.